Torin 1

Catalog No.S2827

Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays; exhibits 1000-fold selectivity for mTOR than PI3K.

Price Stock Quantity  
USD 170 In stock
USD 370 In stock
USD 670 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Torin 1 Chemical Structure

Torin 1 Chemical Structure
Molecular Weight: 607.62

Validation & Quality Control

4 customer reviews :

Quality Control & MSDS

Related Compound Libraries

mTOR Inhibitors with Unique Features

Product Information

  • Compare mTOR Inhibitors
    Compare mTOR Products
  • Research Area
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays; exhibits 1000-fold selectivity for mTOR than PI3K.
Targets mTORC1 [1]
(Cell-free assay)
mTOR [2]
(Cell-free assay)
DNA-PK [2]
(Cell-free assay)
mTORC2 [1]
(Cell-free assay)

 View  More

IC50 2 nM 4.32 nM 6.34 nM 10 nM
In vitro Torin1 inhibits phosphorylation of mTORC1 and mTORC2 substrates in cells at concentrations of 2 and 10 nM, respectively. Moreover, Torin1 exhibits 1000-fold selectivity for mTOR over PI3K (EC50 = 1800 nM) and exhibits 100-fold binding selectivity relative to 450 other protein kinases. [1] [2] Torin1 causes cell cycle arrest through a rapamycin-resistant mechanism that is also independent of mTORC2. Torin1 disrupts mTORC1-dependent phenotypes more completely than rapamycin. Rapamycin-resistant functions of mTORC1 are required for cap-dependent translation. [1] In a recent study, it is reported Torin1 increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
ETK-1NUfMUnBWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGL5XXNKSzVyPUCuNFAxOzB4IN88US=>NUHEXlJMW0GQR1XS
OCUB-MMkC1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX;neHFXUUN3ME2wMlAxOTl2IN88US=>NVjCO4M3W0GQR1XS
DOHH-2M1Hsc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPzZZVKSzVyPUCuNFAzOjVizszNM2PZ[nNCVkeHUh?=
NOS-1NYrQcWd1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIHBbm9KSzVyPUCuNFAzPDJizszNMU\TRW5ITVJ?
L-363NUX2eWJqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFrhfYRKSzVyPUCuNFAzQDRizszNNEfSfo1USU6JRWK=
RL95-2MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGPSWplKSzVyPUCuNFA{OiEQvF2=MVTTRW5ITVJ?
BL-70NEjZZ|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{DISWlEPTB;MD6wNFM{PyEQvF2=MkHvV2FPT0WU
TGBC1TKBMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjV[FlKSzVyPUCuNFA{PzlizszNM3;zOHNCVkeHUh?=
697M1LpOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4PaXGlEPTB;MD6wNFY{PCEQvF2=NXK5NZNyW0GQR1XS
RPMI-8226NGLSe4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rPRWlEPTB;MD6wNFY2OSEQvF2=MUHTRW5ITVJ?
BL-41MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWO0ZVZGUUN3ME2wMlAxPjl4IN88US=>MorVV2FPT0WU
MRK-nu-1NULqfGRzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGjkd5NKSzVyPUCuNFA4ODdizszNNUC0c5NoW0GQR1XS
EW-1NX;5VW9RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPsTWM2OD1yLkCwO|Q6KM7:TR?=MWHTRW5ITVJ?
EVSA-TNWfLd45xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF;MVnJKSzVyPUCuNFA5QTJizszNM4W2bHNCVkeHUh?=
HUTU-80M{C2[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTBwMEC5Nlkh|ryPNV\hRlI4W0GQR1XS
VA-ES-BJM{nN[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\yZ2lEPTB;MD6wNFk5PCEQvF2=NVfmRpJTW0GQR1XS
GCIYNEnxWY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4XvfGlEPTB;MD6wNVAxPyEQvF2=NFfNS5hUSU6JRWK=
ES6MmPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rn[WlEPTB;MD6wNVA5OyEQvF2=MXHTRW5ITVJ?
NALM-6MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEPKfZFKSzVyPUCuNFEyODJizszNNYTB[WtUW0GQR1XS
LB996-RCCMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX;zWo5XUUN3ME2wMlAyOTN5IN88US=>NEf1RmFUSU6JRWK=
EW-16MnfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4T0[mlEPTB;MD6wNVE6OiEQvF2=NH7EWIZUSU6JRWK=
KALS-1NXrVZlExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRTBwMEGxPVgh|ryPM2jDfXNCVkeHUh?=
OPM-2MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoW4TWM2OD1yLkCxNlkh|ryPMkLTV2FPT0WU
KU812NFH1XY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUDUflZ6UUN3ME2wMlAyOjl4IN88US=>NWLVfXA1W0GQR1XS
A4-FukMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWfJR|UxRTBwMEGzNVkh|ryPMVHTRW5ITVJ?
KGNNV\QfZltT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLvbmtOUUN3ME2wMlAyOzV7IN88US=>NFzIOndUSU6JRWK=
KS-1NEiyXIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTBwMEGzPVIh|ryPMnPSV2FPT0WU
no-11NFHUNFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHrkXXBKSzVyPUCuNFE{QTVizszNMlmwV2FPT0WU
PSN1M{f0OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlLWTWM2OD1yLkCxOFA6KM7:TR?=MlXzV2FPT0WU
SK-LMS-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfFNoRUUUN3ME2wMlAyPDF|IN88US=>M33LcnNCVkeHUh?=
LS-411NM2L5cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoXqTWM2OD1yLkCxOFM6KM7:TR?=M4Pl[HNCVkeHUh?=
HT-144M13rXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NInrcJhKSzVyPUCuNFE1PTFizszNM1jq[3NCVkeHUh?=
ACNM4e4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\DVWlEPTB;MD6wNVUh|ryPMW\TRW5ITVJ?
RKOM1\4UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGGyVYxKSzVyPUCuNFE2OzNizszNM4Tq[nNCVkeHUh?=
CMKMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTBwMEG1OFMh|ryPMWPTRW5ITVJ?
GB-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEWxdIhKSzVyPUCuNFE2PTNizszNNUDLUoF3W0GQR1XS
KE-37M3uxXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTEbpNOUUN3ME2wMlAyPTd|IN88US=>M4[xZ3NCVkeHUh?=
no-10MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2nvcGlEPTB;MD6wNVU5PCEQvF2=NE\heFlUSU6JRWK=
MOLT-16M3T4[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYnMZlFoUUN3ME2wMlAyPjJ{IN88US=>M4exfnNCVkeHUh?=
HELNEXNeFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXzJR|UxRTBwMEG2OEDPxE1?NIrOcI1USU6JRWK=
NCI-H1355M3zaV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTBwMEG2OFYh|ryPM2niSnNCVkeHUh?=
IST-MEL1NF;GXWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWTnTnJRUUN3ME2wMlAyPzd2IN88US=>NEXoTG1USU6JRWK=
MHH-PREB-1MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnjenVKSzVyPUCuNFE5OThizszNM1rtZXNCVkeHUh?=
ES8NVK4V|RoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTBwMEG4OFQh|ryPNEHneVRUSU6JRWK=
LC-2-adM2rNeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFvSWXBKSzVyPUCuNFIyOzdizszNM3L0T3NCVkeHUh?=
LAMA-84NIDKdo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTBwMEKxOlch|ryPMoXuV2FPT0WU
BV-173MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrzS|htUUN3ME2wMlAzOjB|IN88US=>M1nVR3NCVkeHUh?=
SW872NWfnPIlYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlLhTWM2OD1yLkCyNlQ4KM7:TR?=MVrTRW5ITVJ?
SK-UT-1MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4LLRmlEPTB;MD6wNlI3OSEQvF2=MWLTRW5ITVJ?
OS-RC-2MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfYTWM2OD1yLkCyN|I{KM7:TR?=M2LVWXNCVkeHUh?=
NCI-H747MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX7Oc5BFUUN3ME2wMlAzOzNizszNM3zWNHNCVkeHUh?=
MZ2-MELMkT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFTr[nRKSzVyPUCuNFI{OzdizszNNWTNUHlIW0GQR1XS
TE-11MlHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkezTWM2OD1yLkCyN|czKM7:TR?=MojOV2FPT0WU
KURAMOCHINHHTb|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfMWJFKSzVyPUCuNFI1OTRizszNNXP4XXM{W0GQR1XS
HD-MY-ZMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVLXW4g6UUN3ME2wMlAzPDJ4IN88US=>MUHTRW5ITVJ?
GI-1MoT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M36ze2lEPTB;MD6wNlQ3QSEQvF2=MnzrV2FPT0WU
LB1047-RCCM3u1fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnvqTWM2OD1yLkCyOFg5KM7:TR?=M2e3dHNCVkeHUh?=
TE-12MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3jBTGlEPTB;MD6wNlU2KM7:TR?=M4LHfHNCVkeHUh?=
MZ7-melNGPIcohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmrMTWM2OD1yLkCyOlA6KM7:TR?=MUfTRW5ITVJ?
MMAC-SFMoTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MljnTWM2OD1yLkCyOlM{KM7:TR?=NVvrNGU4W0GQR1XS
A101DNFfDd45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnfMTWM2OD1yLkCyOlUh|ryPMnLoV2FPT0WU
GR-STM2jjNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTBwMEK2OVUh|ryPNHHtc|ZUSU6JRWK=
MC116M{C2TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGXnPYhKSzVyPUCuNFI3QCEQvF2=M4LrTHNCVkeHUh?=
Ramos-2G6-4C10NXvkS|hqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{C3TWlEPTB;MD6wNlc2KM7:TR?=MX3TRW5ITVJ?
ATN-1M2G1c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MofWTWM2OD1yLkCyO|g6KM7:TR?=NELw[4RUSU6JRWK=
MFH-inoNIrDXm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTBwMEK4NVIh|ryPMV\TRW5ITVJ?
DELMkT5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH;UV3JKSzVyPUCuNFI5OTVizszNMXzTRW5ITVJ?
OCI-AML2NILQSVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4mxXGlEPTB;MD6wNlg4OSEQvF2=NGDZeFFUSU6JRWK=
LXF-289M4jDbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPaSW5IUUN3ME2wMlAzQDd{IN88US=>NVHmXFQyW0GQR1XS
IA-LMNEC3ZnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHnPRohKSzVyPUCuNFI6OTdizszNMX3TRW5ITVJ?
EoL-1-cellMYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTYTWM2OD1yLkCyPVk3KM7:TR?=NWrqb2U1W0GQR1XS
OVCAR-4NFLHUYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXKzUZNUUUN3ME2wMlA{ODl2IN88US=>M3Pqd3NCVkeHUh?=
ES1NFHx[Y9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXTDT|BbUUN3ME2wMlA{ODl5IN88US=>NFHM[W9USU6JRWK=
CESSNX3n[lM5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmnQTWM2OD1yLkCzNFk6KM7:TR?=NGL2SWFUSU6JRWK=
GAKNGPLdYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mor5TWM2OD1yLkCzNVg3KM7:TR?=MUPTRW5ITVJ?
NTERA-S-cl-D1MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MojPTWM2OD1yLkCzNlI3KM7:TR?=MYPTRW5ITVJ?
TE-10NGPtTItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYXJR|UxRTBwMEOzNVEh|ryPNIK0Z3NUSU6JRWK=
CCRF-CEMM4r0bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDSUI5SUUN3ME2wMlA{OzdzIN88US=>MoLuV2FPT0WU
NMC-G1NGXQZXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPaTWM2OD1yLkCzOFQ5KM7:TR?=M4rvfnNCVkeHUh?=
HOP-62NXvjXW1xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHL4bIhKSzVyPUCuNFM2PTZizszNMkXoV2FPT0WU
SH-4MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3f4bmlEPTB;MD6wN|U5OiEQvF2=MnyzV2FPT0WU
NCI-H1648MoX0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml;uTWM2OD1yLkCzOlIzKM7:TR?=NWXlelZVW0GQR1XS
EB-3NGjQbIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHWwZZVKSzVyPUCuNFM3PDNizszNM3nNcHNCVkeHUh?=
BB65-RCCMoW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnvmTWM2OD1yLkCzOlkyKM7:TR?=M4P6c3NCVkeHUh?=
BE-13NXLPOnpRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTBwMEO3OVkh|ryPNIPlcVNUSU6JRWK=
CP67-MELMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXr6NlczUUN3ME2wMlA{PzV7IN88US=>NVXtPHJMW0GQR1XS
SW954MmXZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\T[lVKSzVyPUCuNFM4QSEQvF2=MXPTRW5ITVJ?
TE-5NVWxUYlZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFvOclNKSzVyPUCuNFM5PTRizszNNEL0O2VUSU6JRWK=
HCE-4Ml;jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XUTGlEPTB;MD6wN|g2PSEQvF2=NXTkOZk3W0GQR1XS
LC-1FMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHv5XoFKSzVyPUCuNFM6QDlizszNNUTVO2lDW0GQR1XS
TK10NIfVS|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2WwN2lEPTB;MD6wOFAyQSEQvF2=MnLWV2FPT0WU
SJSA-1NUPBdpo6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXzOV21rUUN3ME2wMlA1OTh6IN88US=>NFvROFdUSU6JRWK=
DaudiNY\POm9DT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLnTWM2OD1yLkC0NlI2KM7:TR?=M3rWbHNCVkeHUh?=
SW982M2nNUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2noO2lEPTB;MD6wOFI1PiEQvF2=NFX5PFFUSU6JRWK=
SF126Mnq5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MofKTWM2OD1yLkC0N|YyKM7:TR?=NXL4Tm1kW0GQR1XS
TE-15MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVv6R5k2UUN3ME2wMlA1PDN3IN88US=>MWXTRW5ITVJ?
COLO-684MlTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rYVmlEPTB;MD6wOFU3OSEQvF2=NV;Cd2ExW0GQR1XS
8-MG-BANF\3Vo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\lfWpKUUN3ME2wMlA1PjJ7IN88US=>M2\DenNCVkeHUh?=
NB13NIPqT5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEP1[YdKSzVyPUCuNFQ4PzZizszNNHXVcXlUSU6JRWK=
HCC1599NXfDUWJbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DQXGlEPTB;MD6wOFg4QSEQvF2=NIGyNYRUSU6JRWK=
SK-PN-DWNXy4WW9bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2i4VGlEPTB;MD6wOFk1QSEQvF2=NIPNeWdUSU6JRWK=
ALL-PONGGxPG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVLJR|UxRTBwMES5OVYh|ryPNEWyOVJUSU6JRWK=
NB6NHzlW49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7TfHdKSzVyPUCuNFUzPzFizszNM4Xi[3NCVkeHUh?=
IST-SL2M3Pw[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoLBTWM2OD1yLkC1N|YzKM7:TR?=Ml3jV2FPT0WU
BB30-HNCNHnYXoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mk[5TWM2OD1yLkC1O|Mh|ryPMUXTRW5ITVJ?
SW962MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHNTWM2OD1yLkC1O|Y{KM7:TR?=NYm3cJFyW0GQR1XS
TGBC24TKBM4[w[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWrYe5M1UUN3ME2wMlA2Pzl7IN88US=>NXrV[YE2W0GQR1XS
KINGS-1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV7tWo1tUUN3ME2wMlA2QDB|IN88US=>MlfJV2FPT0WU
HC-1NGjHNmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTBwMEW4Nlch|ryPMXrTRW5ITVJ?
RS4-11MkHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoL1TWM2OD1yLkC1PVM5KM7:TR?=M{TPcHNCVkeHUh?=
LS-123MoTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfpTWM2OD1yLkC1PVQzKM7:TR?=M2W0RnNCVkeHUh?=
A3-KAWMlXDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\IOZJ6UUN3ME2wMlA3OjJ3IN88US=>NXXhc|M6W0GQR1XS
SNB75M{fobGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HKPGlEPTB;MD6wOlM1OSEQvF2=MknCV2FPT0WU
SRMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3TxZ2lEPTB;MD6wOlM4PCEQvF2=M2m4[nNCVkeHUh?=
LOUCYNWPkdlUxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUPaXVdYUUN3ME2wMlA3Ozl2IN88US=>NFvGSXdUSU6JRWK=
K5NXjFXYx{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{HMXGlEPTB;MD6wOlQxOyEQvF2=MWnTRW5ITVJ?
BeckerNH3ae2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{Oy[2lEPTB;MD6wOlQzKM7:TR?=MmTTV2FPT0WU
CTV-1NF[2WnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjrTWM2OD1yLkC2OVQ5KM7:TR?=MUPTRW5ITVJ?
KLENGnEXWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{i2SGlEPTB;MD6wOlU5PCEQvF2=M2\PTXNCVkeHUh?=
MZ1-PCMkPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGjCfWlKSzVyPUCuNFY2QThizszNNHKxN5JUSU6JRWK=
MOLT-4M4T1WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTBwME[2NFUh|ryPMknoV2FPT0WU
MLMAM3rhO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX;5RYFJUUN3ME2wMlA3PzhizszNNFHsRYdUSU6JRWK=
A388NX:wc5JMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTBwME[4PVMh|ryPMX;TRW5ITVJ?
MV-4-11M2DKWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfRSWVDUUN3ME2wMlA3QTl3IN88US=>MV3TRW5ITVJ?
DSH1M1ziOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTBwMEexO|Mh|ryPNVvm[HJCW0GQR1XS
MONO-MAC-6Mlr0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfmTWM2OD1yLkC3NlEzKM7:TR?=NWXqUnlGW0GQR1XS
ARH-77NYDaN4QyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRTBwMEeyO|gh|ryPMoXnV2FPT0WU
LB771-HNCM{H3Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLqTWM2OD1yLkC3OVQ6KM7:TR?=NInIRZFUSU6JRWK=
PF-382NGDhNXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXTFdFluUUN3ME2wMlA4PTZ7IN88US=>NWDXN2NmW0GQR1XS
KM12MojQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NI[2XGhKSzVyPUCuNFc3PCEQvF2=NHrwUZhUSU6JRWK=
HAL-01MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwMEe2OVgh|ryPNEfLd3dUSU6JRWK=
RPMI-8402MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1[xfGlEPTB;MD6wO|c5QSEQvF2=NXO2VZVpW0GQR1XS
OMC-1NFfuc3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn72TWM2OD1yLkC3PFA1KM7:TR?=MVvTRW5ITVJ?
HTNWrVOVJQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoTYTWM2OD1yLkC4JO69VQ>?MX3TRW5ITVJ?
QIMR-WILNV;hTYdTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYHCdoR3UUN3ME2wMlA5ODV3IN88US=>MYHTRW5ITVJ?
KNS-42MoXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWHzUHFTUUN3ME2wMlA5OjB|IN88US=>NYX3Z3IyW0GQR1XS
BC-3M{S4Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4KzWmlEPTB;MD6wPFIxPCEQvF2=MUTTRW5ITVJ?
ES4NYDoS4plT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4\XfWlEPTB;MD6wPFI6PiEQvF2=M2XIPHNCVkeHUh?=
NCI-H23NGHjWHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlfmTWM2OD1yLkC4OFQh|ryPMl7yV2FPT0WU
LB2518-MELM1GzNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4S1XGlEPTB;MD6wPFY6PiEQvF2=M3TkOnNCVkeHUh?=
LC4-1MnG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnLVTWM2OD1yLkC4O|M5KM7:TR?=M3j3dnNCVkeHUh?=
SIG-M5NIPkSHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEfTTG9KSzVyPUCuNFg6ODRizszNNWLSbplyW0GQR1XS
LP-1M4fmWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\vTWM2OD1yLkC4PVM5KM7:TR?=NWe5WllUW0GQR1XS
TE-8M3vVWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHz2doFKSzVyPUCuNFkxOTZizszNNHvPcWFUSU6JRWK=
K-562MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIPISIZKSzVyPUCuNFkyOiEQvF2=NVzx[|JwW0GQR1XS
J-RT3-T3-5M2PIfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX;JR|UxRTBwMEmxOVMh|ryPMmrxV2FPT0WU
DU-4475MmDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4m0VWlEPTB;MD6wPVE3PSEQvF2=M2PjdHNCVkeHUh?=
RXF393NE\XN|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTBwMEm0OlIh|ryPMWXTRW5ITVJ?
NB5M1niemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHfJNHBKSzVyPUCuNFk3OjVizszNNH7ad5JUSU6JRWK=
A704MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV3WT2hGUUN3ME2wMlA6PzRzIN88US=>M2XCVHNCVkeHUh?=
SF268NIP2XZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVHGdYp6UUN3ME2wMlA6QDJ3IN88US=>NF3WTIZUSU6JRWK=
UACC-257MoSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXQfYNKSzVyPUCuNFk5OzNizszNMUjTRW5ITVJ?
L-428MnGxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIfqVXZKSzVyPUCuNVA{OiEQvF2=MVjTRW5ITVJ?
ST486M3LmfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\hTWM2OD1yLkGwOlA3KM7:TR?=Ml34V2FPT0WU
SK-MM-2MkH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYrvWXlIUUN3ME2wMlExPzB7IN88US=>MWjTRW5ITVJ?
COR-L279NYrocHlnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{nVc2lEPTB;MD6xNFg{OiEQvF2=NX\sbJlpW0GQR1XS
JiyoyeP-2003MlvES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTBwMUC4OFMh|ryPMnHTV2FPT0WU
GT3TKBMl7PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX\tSmM6UUN3ME2wMlExQTF6IN88US=>MmH3V2FPT0WU
HCE-TNEOzPWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3jINWlEPTB;MD6xNFk1KM7:TR?=M3v0W3NCVkeHUh?=
SBC-1MlvhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTBwMUGxNVkh|ryPNWHZSpg5W0GQR1XS
KNS-81-FDMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkW2TWM2OD1yLkGxNlc{KM7:TR?=MUPTRW5ITVJ?
NCI-H2126NVTVPHFGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWjZboRTUUN3ME2wMlEyOzl2IN88US=>MoXFV2FPT0WU
EM-2MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUPJR|UxRTBwMUG1Nlkh|ryPNWPuS3FUW0GQR1XS
JARNVTkTZlLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHZWnRNUUN3ME2wMlEyPTl6IN88US=>NIDsfGNUSU6JRWK=
NB17MnvLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTBwMUG2OVIh|ryPM33kbHNCVkeHUh?=
LB647-SCLCNEDHNWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXTJR|UxRTBwMUG3NFUh|ryPNHPNPIFUSU6JRWK=
CAL-148MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVPwb28xUUN3ME2wMlEyQCEQvF2=NX;TdoRQW0GQR1XS
K052NGXH[o1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1:5Z2lEPTB;MD6xNVg2OSEQvF2=MWXTRW5ITVJ?
KARPAS-299M3zyOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkPkTWM2OD1yLkGyNlM{KM7:TR?=MnrUV2FPT0WU
KARPAS-422NVvNV5ZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTsTWM2OD1yLkGyOFMzKM7:TR?=NWe3R|JlW0GQR1XS
LOXIMVINIr3U3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NILGOI1KSzVyPUCuNVI2OTVizszNMmPlV2FPT0WU
SCC-3MnnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHrvPHZKSzVyPUCuNVI5PTFizszNM2PuVnNCVkeHUh?=
LU-139M1KzbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX;OS3E2UUN3ME2wMlEzQTd3IN88US=>M1rBTHNCVkeHUh?=
COLO-320-HSRNHvi[FhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml:3TWM2OD1yLkGzNFg3KM7:TR?=M1LFN3NCVkeHUh?=
ONS-76MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTBwMUOxN{DPxE1?MVLTRW5ITVJ?
U-266NUD4RVZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVf0[|U{UUN3ME2wMlE{OjR3IN88US=>NIHvbZRUSU6JRWK=
HHNHnxSXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjSbYIyUUN3ME2wMlE{PTN3IN88US=>NULh[4J6W0GQR1XS
BB49-HNCMojOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1jDSmlEPTB;MD6xN|U5PyEQvF2=NE\HXYJUSU6JRWK=
NCI-SNU-5NELZdGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHDTWM2OD1yLkGzOVk3KM7:TR?=NGO4OHlUSU6JRWK=
C2BBe1NI\Oe3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnwWmpQUUN3ME2wMlE{PzR4IN88US=>MkPpV2FPT0WU
ML-2MofVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXTJR|UxRTBwMUO5OVMh|ryPNVXQSFFzW0GQR1XS
SCHM362fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3u2ZmlEPTB;MD6xN|k4PCEQvF2=Mof0V2FPT0WU
NCI-H82MmXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4i5TmlEPTB;MD6xOFExPCEQvF2=Mn7kV2FPT0WU
MDA-MB-134-VIMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4rDOGlEPTB;MD6xOFI2OiEQvF2=NXvnc5o5W0GQR1XS
SK-N-DZMlzHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVfJR|UxRTBwMUS3NVkh|ryPM1\ibnNCVkeHUh?=
HL-60M2W5SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTBwMUS5NkDPxE1?M3;EZ3NCVkeHUh?=
LB373-MEL-DM2\OW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVnKenRvUUN3ME2wMlE2PTN7IN88US=>MlPHV2FPT0WU
LB831-BLCNH7LXIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEXtbGxKSzVyPUCuNVYxPzZizszNMUjTRW5ITVJ?
SK-NEP-1M1Lyfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTBwMU[xNFEh|ryPM2nydHNCVkeHUh?=
IMR-5MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHVO4NUUUN3ME2wMlE3PDh|IN88US=>NUDyeVNVW0GQR1XS
Calu-6Ml7rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NID0PWVKSzVyPUCuNVY2OzdizszNNW\U[YV[W0GQR1XS
NCI-H1882NGThW2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{Xz[mlEPTB;MD6xOlczQCEQvF2=M1j3NnNCVkeHUh?=
NCI-H446MkDDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3Xuc2lEPTB;MD6xOlg6OSEQvF2=MVPTRW5ITVJ?
GI-ME-NNYKzc5ZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPOTWM2OD1yLkG4NFIh|ryPM13iTXNCVkeHUh?=
MPP-89MkD4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml7XTWM2OD1yLkG4NVIyKM7:TR?=NVzwdGtIW0GQR1XS
CGTH-W-1M2njWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTBwMUi0N|Yh|ryPNWfJUmp6W0GQR1XS
MEG-01MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIr6fJVKSzVyPUCuNVg3OjhizszNMoXWV2FPT0WU
NCI-H748NHfuRnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYXmfXN3UUN3ME2wMlE5QTFzIN88US=>MoXBV2FPT0WU
COLO-829M1nhbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\mZ4xNUUN3ME2wMlIxPjd|IN88US=>NFvlXndUSU6JRWK=
GOTOM3zUe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXW3bHp{UUN3ME2wMlIxPzNizszNNYDQdYpQW0GQR1XS
EW-3MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlXjTWM2OD1yLkKxO|E5KM7:TR?=NFPZXIlUSU6JRWK=
KY821NILVUolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nwSGlEPTB;MD6yNlA1PSEQvF2=NWjDc4NqW0GQR1XS
CTB-1M33hc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrrbpVKSzVyPUCuNlIzOjhizszNNUWxVJpUW0GQR1XS
TALL-1M4f6fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnobmFKSzVyPUCuNlI6OjFizszNMXXTRW5ITVJ?
NCI-H209M2rRVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH25OYlKSzVyPUCuNlI6PjJizszNM4rvSnNCVkeHUh?=
IST-MES1MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTBwMkO1NUDPxE1?MkjFV2FPT0WU
DMS-114M{HDSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHUd5c5UUN3ME2wMlI{QTl|IN88US=>NFHFZYpUSU6JRWK=
SNU-C2BNH;lRmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzkPY1XUUN3ME2wMlI1OzF4IN88US=>NY\lVpozW0GQR1XS
DG-75MoP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTBwMk[xPVUh|ryPM37MPHNCVkeHUh?=
D-336MGMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVz1TXZTUUN3ME2wMlI3PTV5IN88US=>NEnBPGFUSU6JRWK=
KMOE-2M3PobGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFjaclVKSzVyPUCuNlc2OzhizszNMofUV2FPT0WU
NB1M1vLR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWDJR|UxRTBwMke5NlYh|ryPNXT0dlB1W0GQR1XS
RH-1M3n3[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDHTWM2OD1yLkK3PVg6KM7:TR?=NUXzOJV1W0GQR1XS
TE-1M3mzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnKb4g3UUN3ME2wMlI5PDd7IN88US=>NGX3bYFUSU6JRWK=
RPMI-6666NVfLVYZVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPpS|dlUUN3ME2wMlI5QDRizszNNY\FXohqW0GQR1XS
TE-9NVviUmluT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{TwTWlEPTB;MD6yPFk5PSEQvF2=MX3TRW5ITVJ?
BT-474Mo\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTBwMkmzN|Qh|ryPNUfpb2lCW0GQR1XS
COLO-668MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRTBwMkm0Nlkh|ryPMl\FV2FPT0WU
NCI-H1581NHPOTFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkW1TWM2OD1yLkK5Olg6KM7:TR?=NFT3RmpUSU6JRWK=
MN-60MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXnTWM2OD1yLkK5PVA2KM7:TR?=NEfMfo5USU6JRWK=
L-540MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2W3UmlEPTB;MD6zNFA5OSEQvF2=Mor2V2FPT0WU
MOLT-13MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGL1cYZKSzVyPUCuN|AyQDNizszNMo\iV2FPT0WU
NCI-SNU-16M2LEVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIfqeYxKSzVyPUCuN|AzODVizszNNVvW[VJiW0GQR1XS
NCI-H64MnfHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mkn4TWM2OD1yLkOwN|MyKM7:TR?=NXHEbZpTW0GQR1XS
CP66-MELNGPXW5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTBwM{G0NVUh|ryPMmnlV2FPT0WU
NB69Mn7SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUnJR|UxRTBwM{KxPFgh|ryPNFvtdIRUSU6JRWK=
NCI-H2196M3W4fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPSW2t3UUN3ME2wMlM{ODN4IN88US=>NGOyXGFUSU6JRWK=
MHH-CALL-2MnTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEfTW3ZKSzVyPUCuN|M1PjhizszNNHz1[mRUSU6JRWK=
HCC2157Mk\JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHXQdmZKSzVyPUCuN|M6PTRizszNNUnNS|NPW0GQR1XS
LS-1034MoD2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkXDTWM2OD1yLkO2N|g5KM7:TR?=NUjtWXc4W0GQR1XS
BOKUM4\3bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUTEUmJjUUN3ME2wMlM4OTl7IN88US=>NV3KUphqW0GQR1XS
GDM-1NWH4UZBbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLxdmJPUUN3ME2wMlM4OjN2IN88US=>M{X6[3NCVkeHUh?=
TGWNUnaW29bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTBwM{e0OVMh|ryPMkmxV2FPT0WU
SNU-C1Mkj3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;z[mlEPTB;MD6zPFIyPSEQvF2=NWXEXHZ4W0GQR1XS
LS-513MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkP0TWM2OD1yLkO5NFcyKM7:TR?=NX7XZnhyW0GQR1XS
NOMO-1NY\wZYszT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoHnTWM2OD1yLkO5PVcyKM7:TR?=MVLTRW5ITVJ?
MS-1NV\TT3R[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULIbpM3UUN3ME2wMlQxOTd5IN88US=>MX7TRW5ITVJ?
EKVXM2PESWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTBwNES0OlEh|ryPMoLUV2FPT0WU
SK-MEL-2NFv0bmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7UWWNKSzVyPUCuOFY1KM7:TR?=MVzTRW5ITVJ?
HCC1187NEG0ZZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfme|BKSzVyPUCuOFY4PjhizszNMXzTRW5ITVJ?
HCC2218M1nvVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rxPWlEPTB;MD60O|IzPyEQvF2=NITvSYZUSU6JRWK=
NCI-H187MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHzmSIFKSzVyPUCuOFc5PCEQvF2=NE\xdFJUSU6JRWK=
DBM1LDXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmGwTWM2OD1yLkWwNFU2KM7:TR?=M33x[nNCVkeHUh?=
NCI-H69NVPaTlNuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmnRTWM2OD1yLkWwNlQ4KM7:TR?=NUmwbnZZW0GQR1XS
NCI-H1694NGHNSVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml31TWM2OD1yLkWwOlk4KM7:TR?=MnPyV2FPT0WU
CA46NYjCTlh6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTzbZVGUUN3ME2wMlUxQTF5IN88US=>NUnIR|lpW0GQR1XS
EHEBMn21S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWT0cFdjUUN3ME2wMlUyOTl|IN88US=>MlPqV2FPT0WU
NCCITMoriS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHzXO2JKSzVyPUCuOVQ{OjFizszNNIDxVGpUSU6JRWK=
NCI-H720MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTBwNUS5OlIh|ryPNF\DOVBUSU6JRWK=
LU-134-ANHvhUnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2OyeWlEPTB;MD61OVI6PiEQvF2=NYDDSHI4W0GQR1XS
MC-CARM3TyTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTBwNUW0N|Eh|ryPNXLUUIE6W0GQR1XS
NEC8NVPZdFNYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHUTWM2OD1yLkW2NVczKM7:TR?=NFPme4ZUSU6JRWK=
NCI-H524MoH3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LSWGlEPTB;MD61PFc1QCEQvF2=MULTRW5ITVJ?
NCI-H1963M4f3Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M122dmlEPTB;MD62NlU5KM7:TR?=M1XpVXNCVkeHUh?=
SU-DHL-1M4X1d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPrTWM2OD1yLk[0OVI3KM7:TR?=MnXRV2FPT0WU
NCI-H1522M1XlZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXzJR|UxRTBwNkS4PFMh|ryPNEO1[pVUSU6JRWK=
NCI-H1155NXTsTW9nT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml7uTWM2OD1yLk[1N|Uh|ryPNXX5XZFbW0GQR1XS
D-263MGMlH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTBwNk[xNFEh|ryPMmLoV2FPT0WU
TE-6NVXuSpRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHrnempKSzVyPUCuOlgyODRizszNMVzTRW5ITVJ?
NCI-H1417NWfXOVZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFLOfo9KSzVyPUCuOlk4OTFizszNNGL1UpRUSU6JRWK=
NCI-H510ANGe5clZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV[yWHZZUUN3ME2wMlc4OjN4IN88US=>M2r1VnNCVkeHUh?=
KARPAS-45NFjaO3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2m5TGlEPTB;MD63PFI{PSEQvF2=MoPoV2FPT0WU
IST-SL1NUHoR3RGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTBwOEW4NlUh|ryPNX;sUm9tW0GQR1XS
COLO-824MlzKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXrxVHByUUN3ME2wMlg4QDN3IN88US=>NF7xXFVUSU6JRWK=
NCI-H526MkPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTBwOUC5OVgh|ryPNHrweJZUSU6JRWK=
NCI-H719M3X6bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTBwOU[2OVch|ryPNUDCPY12W0GQR1XS
SF539NX\GZo5jT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTBwOUizPVYh|ryPNWiwd|ZpW0GQR1XS
NKM-1NEfSR3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MljsTWM2OD1yLkm4OlY{KM7:TR?=M2fOT3NCVkeHUh?=
A253MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX3ESm1KUUN3ME2wMlk5QDh3IN88US=>NXvpNW54W0GQR1XS
TE-441-TMofXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MknqTWM2OD1zLkC0N|Uh|ryPMVnTRW5ITVJ?
COR-L88MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTFwMUGzOVQh|ryPM3nUZXNCVkeHUh?=
CPC-NMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTFwMUW4PFgh|ryPNXTVOlkyW0GQR1XS
NCI-H2107NYH1O|JuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX\JR|UxRTFwMUeyOlEh|ryPNX20Wm1lW0GQR1XS
ECC4MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3T6UWlEPTB;MT6xPFY6OyEQvF2=NVLhfWtvW0GQR1XS
NCI-H2141MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTFwMUmyPVkh|ryPNGD6Z|JUSU6JRWK=
NCI-H1770NVP6T2pmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoLVTWM2OD1zLkOyPVI5KM7:TR?=NInVO|VUSU6JRWK=
NCI-SNU-1M2jVcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGLkc5VKSzVyPUGuN|MxPCEQvF2=NFXrO3RUSU6JRWK=
LU-165NWD2dnE6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVHD[lN4UUN3ME2xMlQ2PDZ5IN88US=>M3jBdHNCVkeHUh?=
RajiMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTFwNEeyOVkh|ryPM4KwNnNCVkeHUh?=
EW-24NECwOoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTITWM2OD1zLkW0OlE6KM7:TR?=MYHTRW5ITVJ?
KP-N-RT-BM-1NW\NWpRPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVjJR|UxRTFwNU[1OVEh|ryPNELCOY1USU6JRWK=
SK-MEL-1MkjzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1[zfGlEPTB;MT62OFg4PyEQvF2=NIrPT|JUSU6JRWK=
SCLC-21HNUDaUm9oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGjoSWRKSzVyPUGuOlY3PTFizszNMUXTRW5ITVJ?
SIMANYrncG5VT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHf3OYlKSzVyPUGuOlgzOzNizszNMUXTRW5ITVJ?
NCI-H1304MnfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmXjTWM2OD1zLkewO|Y2KM7:TR?=M1PuZXNCVkeHUh?=
REHNIPSe4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYHsR4dMUUN3ME2xMlcyODd6IN88US=>NFTCT2tUSU6JRWK=
KP-N-YSNYXPOVhGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MonOTWM2OD1zLkmzOVUyKM7:TR?=NIDOcnpUSU6JRWK=
DMS-153NEGwXIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTFwOUe1PUDPxE1?MXnTRW5ITVJ?
NB10NGDMO29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXrmcZI3UUN3ME2yMlIxQDd6IN88US=>MY\TRW5ITVJ?
NCI-H345NFXiXnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13m[mlEPTB;Mj62NVkxPSEQvF2=NFTKNXJUSU6JRWK=
SK-N-FIMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHqc49kUUN3ME2yMlc2OzhzIN88US=>MXXTRW5ITVJ?
NCI-H1092NF:2[nFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHDXFJKSzVyPUKuPVU{QTRizszNMXzTRW5ITVJ?
KM-H2M{Hwc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUP0eWhyUUN3ME2zMlY2Ozl4IN88US=>M3u4c3NCVkeHUh?=
KG-1M3vwcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHzEPGVKSzVyPUOuO|E3QDhizszNMl;5V2FPT0WU
D-283MEDNXTY[Ig1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;pRWJKSzVyPUOuO|U5PyEQvF2=NUmweI5YW0GQR1XS
LU-65Mo\1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvMWm1KSzVyPUSuNVE1QDVizszNNG\xOpFUSU6JRWK=
MSTO-211HM4LyXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2n1PWlEPTB;ND6xPFg6QCEQvF2=M4DtfnNCVkeHUh?=
NCI-H2081NGDwXGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXG0dIhqUUN3ME20MlI6OTd2IN88US=>NFjZRVFUSU6JRWK=
D-247MGNGfl[5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDLeHN1UUN3ME20MlQ{OTlzIN88US=>MX7TRW5ITVJ?
P31-FUJMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrFOpdKSzVyPUSuOFUxOTlizszNNH\qZXNUSU6JRWK=
DMS-79MofRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH7CO3RKSzVyPUSuPVMyQDNizszNNXTqXlBmW0GQR1XS
KASUMI-1M4PBfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIPoSJFKSzVyPUSuPVc2ODlizszNMnLLV2FPT0WU
JVM-3M3XwPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTVwMkWwNVQh|ryPNH3kendUSU6JRWK=
LAN-6NVPDTWlkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULNUIZIUUN3ME21MlUyPzN4IN88US=>NVvrdG9xW0GQR1XS
DJM-1MnTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\Jboh6UUN3ME21MlU3ODJ7IN88US=>M3:3S3NCVkeHUh?=
JVM-2MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkXDTWM2OD13Lk[3NFkzKM7:TR?=NIOxWllUSU6JRWK=
U-87-MGNH3aNpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmHjTWM2OD13Lki5PVY1KM7:TR?=M2HpOXNCVkeHUh?=
SHP-77M13uXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTVwOUS5Nlgh|ryPM4XTVHNCVkeHUh?=
RPMI-8866MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkSzTWM2OD14LkK3NFE{KM7:TR?=NIXKdJBUSU6JRWK=
ES7NHL6R41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXmTWM2OD14LkO5PVI1KM7:TR?=NEnXUnBUSU6JRWK=
WSU-NHLMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnW3TWM2OD14LkWxOlA6KM7:TR?=MnnhV2FPT0WU
CAS-1MmHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MknFTWM2OD15LkC5O|Q6KM7:TR?=MmHiV2FPT0WU
MHH-NB-11M4PQeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIDNcIVKSzVyPUiuNlMyPTJizszNMoDpV2FPT0WU
ES5M{K5[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37aSGlEPTB;OT61NlI5PiEQvF2=MoS3V2FPT0WU
HDLM-2M4\sPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\OO2lEPTB;OT65OVkxOiEQvF2=MWDTRW5ITVJ?
NCI-H2171MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF\NWJBKSzVyPUGwMlU6OjdizszNNYfFSW1qW0GQR1XS
LNCaP-Clone-FGCMnjDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlrmTWM2OD1zMT6zO|E5KM7:TR?=Mo\0V2FPT0WU
NCI-H1395MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzXTWM2OD1zMj6yOlk6KM7:TR?=M{nlZnNCVkeHUh?=
NCI-H1436M4XZR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUjnNnBGUUN3ME2xN{4{OTl3IN88US=>Ml23V2FPT0WU
RCC10RGBM3HrVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTF|LkOyNlEh|ryPMmjOV2FPT0WU
SW684NGPmUHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXOOYRKSzVyPUGzMlk4QTdizszNNWjCTVl6W0GQR1XS
NCI-H1650NXXLTFZLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\JRYc3UUN3ME2xOU4xPDR5IN88US=>MkTUV2FPT0WU
EW-13M2LMcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4XDT2lEPTB;MUWuNlAzOSEQvF2=M4O0VHNCVkeHUh?=
EC-GI-10NFfZUWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTF3Lki2OFQh|ryPNXr0cWRFW0GQR1XS
CHP-126NETYOXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXPJR|UxRTF5LkG5NVgh|ryPNHHTN4tUSU6JRWK=
NCI-H226MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRTF6LkC0NFMh|ryPNEGxNmFUSU6JRWK=
NCI-H1838NWX0cIVOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUjJTmRnUUN3ME2yNE4yQDR6IN88US=>NELwXoNUSU6JRWK=
EW-11NYO1[WwzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnzRTWM2OD1{ND6yO|E5KM7:TR?=MonJV2FPT0WU
EB2MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTNzLkWzNVgh|ryPMUTTRW5ITVJ?
D-502MGNYfvSI5vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkDKTWM2OD12Mz65NlI6KM7:TR?=NWm3bIFVW0GQR1XS
U-698-MMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MU\JR|UxRTR6Lki2O|Eh|ryPNFvpWY5USU6JRWK=
ES3NHzi[4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NITCfFNKSzVyPUS5MlM5QTNizszNMWPTRW5ITVJ?

... Click to View More Cell Line Experimental Data

In vivo Torin1 is efficacious at a dose of 20 mg/kg in a U87MG xenograft model and demonstrates good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

mTORC1 and mTORC2 in Vitro Kinase Assays To produce soluble mTORC1, HEK-293T cell lines that stably express N-terminally FLAG-tagged Raptor are generated using vesicular stomatitis virus G-pseudotyped MSCV retrovirus. For mTORC2, similar HeLa cells that stably express N-terminally FLAG-tagged Protor-1 are generated. Both complexes are purified by lysing cells in 50 mm HEPES, pH 7.4, 10 mm sodium pyrophosphate, 10 mm sodium β-glycerophosphate, 100 mm NaCl, 2 mm EDTA, 0.3% CHAPS. Cells are lysed at 4 °C for 30 min, and the insoluble fraction is removed by microcentrifugation at 13,000 rpm for 10 min. Supernatants are incubated with FLAG-M2 monoclonal antibody-agarose for 1 h and then washed three times with lysis buffer and once with lysis buffer containing a final concentration of 0.5 M NaCl. Purified mTORC1 is eluted with 100 μg/mL 3×FLAG peptide in 50 mm HEPES, pH 7.4, 100 mm NaCl. Eluate can be aliquoted and stored at -80 °C. Substrates S6K1 and Akt1 are purified. Kinase assays are performed for 20 min at 30 °C in a final volume of 20 μL consisting of the kinase buffer (25 mm HEPES, pH 7.4, 50 mm KCl, 10 mm MgCl2, 500 μm ATP) and 150 ng of inactive S6K1 or Akt1 as substrates. Reactions are stopped by the addition of 80 μL of sample buffer and boiled for 5 min. Samples are subsequently analyzed by SDS-PAGE and immunoblotting.

Cell Assay: [1]

Cell lines MEFs
Concentrations ~250 nM
Incubation Time 4 days
Method Cell viability is assessed with the CellTiter-Glo Luminescent Cell Viability Assay. On Day 0, 96-well plates are seeded with 500 cells per well and grown overnight. On Day 1, cells are treated with the appropriate compounds and subsequently analyzed on Days 3-5. For analysis, plates are incubated for 60 min at room temperature; 50 μL of CellTiter-Glo reagent is added to each well, and plates are mixed on an orbital shaker for 12 min. Luminescence is quantified on a standard plate luminometer.

Animal Study: [2]

Animal Models U87MG xenograft model
Formulation Torin1 powder is first dissolved at 25 mg/mL in 100% N-methyl-2-pyrrolidone and subsequently diluted 1:4 with sterile 50% PEG400 to a final concentration of 5 mg/mL
Dosages 20 mg/kg
Administration Administered via i.p. once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Thoreen CC, et al, J Biol Chem, 2009, 284(12), 8023-8032.

[2] Liu Q, et al, J Med Chem, 2010, 53(19), 7146-7155.

view more

Chemical Information

Download Torin 1 SDF
Molecular Weight (MW) 607.62
Formula

C35H28F3N5O2

CAS No. 1222998-36-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 2 mg/mL (3.29 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG 400+0.5% Tween80+5% Propylene glycol 30mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name Benzo[h]-1,6-naphthyridin-2(1H)-one, 1-[4-[4-(1-oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)-

Frequently Asked Questions

  • Question 1
    How to re-constitute the inhibitor for i.p. administration?

    Answer: S2827 Torin 1 can be dissolved in 5% DMSO/30% PEG 300/ddH2O at 0.25 mg/ml clearly, and in 10% DMSO/corn oil at 0.5 mg/ml, it is also a clear solution.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related mTOR Products

  • MHY1485

    MHY1485 is a potent, and cell-permeable mTOR activator, and also potently inhibits autophagy.

  • CHIR-99021 (CT99021)

    CHIR-99021 (CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively.

  • Dorsomorphin

    Dorsomorphin is a potent, reversible, selective AMPK inhibitor with Ki of 109 nM in cell-free assays, exhibiting no significant inhibition of several structurally related kinases including ZAPK, SYK, PKCθ, PKA, and JAK3. Also inhibits type I BMP receptor activity.

  • Rapamycin (Sirolimus)

    Rapamycin (Sirolimus) is a specific mTOR inhibitor with IC50 of ~0.1 nM HEK293 cells.

  • Everolimus (RAD001)

    Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay.

  • AZD8055

    AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM in MDA-MB-468 cells with excellent selectivity (∼1,000-fold) against PI3K isoforms and ATM/DNA-PK. Phase 1.

    Features:First drug to inhibit both types of mTOR protein.

  • Temsirolimus (CCI-779, NSC 683864)

    Temsirolimus (CCI-779, NSC 683864) is a specific mTOR inhibitor with IC50 of 1.76 μM in a cell-free assay.

  • INK 128 (MLN0128)

    INK 128 (MLN0128) is a potent and selective mTOR inhibitor with IC50 of 1 nM in cell-free assays; >200-fold less potent to class I PI3K isoforms, superior in blocking mTORC1/2 and sensitive to pro-invasion genes (vs Rapamycin). Phase 1.

  • Tacrolimus (FK506)

    Tacrolimus (FK506) is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity in T cells by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex.

  • KU-0063794

    KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2 with IC50 of ~10 nM in cell-free assays; no effect on PI3Ks.

Recently Viewed Items

Tags: buy Torin 1 | Torin 1 supplier | purchase Torin 1 | Torin 1 cost | Torin 1 manufacturer | order Torin 1 | Torin 1 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us